Diagnostics & Emerging Care Consulting
Can integrated diagnostics help you outperform your competitors by 2x?
Partners
Who Trust Us
Enabling Next-Generation Care Models with Strategic Insights
Healthcare is shifting toward ambulatory, preventive, and connected care, making diagnostics central to integrated care delivery. Organizations must balance innovation, operational efficiency, and commercialization to stay competitive.
With rising payer demand for measurable outcomes, providers seeking seamless workflow integration, and patients expecting better access, transparency, and personalization, success now depends more on partnerships, value propositions, and scalable operating models that connect diagnostics, data, and care delivery across the full care journey.
Stellarix helps organizations identify growth opportunities, strengthen portfolio strategies, and navigate clinical and regulatory complexities through market intelligence and strategic advisory.
Outpatient Care
Ambulatory Care
Diagnostic Convergence
Remote Diagnostics
Clinical Data Interoperability
Core Focus Areas
Enabling the next generation of connected, intelligent care.
Diagnostic Imaging & Radiation Systems
Imaging infrastructure is aging as providers invest in AI-enabled and connected technologies. Around 25% of CT and MRI systems have exceeded their replacement timelines, making modernization decisions increasingly strategic. We are assisting companies in streamlining their investments, equipment lifecycles, and portfolio performance.
Critical Care, Surgical & Patient Monitoring
Reliable clinical equipment is essential for uninterrupted care delivery. Manufacturers using predictive maintenance programs report up to 20% lower service costs. We are helping clients strengthen equipment reliability, lifecycle offerings, and service strategies.
Clinical & Laboratory Equipment
Automation is transforming laboratory performance. Integrated diagnostic platforms can reduce turnaround times by 30–40% while improving operational efficiency. We are supporting companies to align innovation, market access, and portfolio strategies.
Rehabilitation, Assistive & Home Healthcare
Demand for home-based care continues to grow with connected rehabilitation technologies. Integrated monitoring solutions can reduce hospital readmissions by nearly 20%. We help manufacturers strengthen product strategies and commercialization for evolving care models.
Hospital Infrastructure & Sterile Processing
Modern healthcare infrastructure is critical to patient safety and clinical efficiency. Digitally integrated sterile processing workflows reduce instrument turnaround time by up to 30%. We support organizations in modernizing infrastructure strategies and maximizing long-term asset value.
Need Strategic Guidance for Your Business?
Strategic hurdles in Diagnostics & Emerging Care
Structural pressures impacting the adoption, integration, and scalability of diagnostics and emerging care.
Fragmented Care Delivery and Integration Gaps
Care delivery is decentralizing at a rapid pace, but data remains fragmented. With 40% of patient health data remaining siloed across incompatible frameworks, it is constraining coordinated care, reducing the value of connected diagnostics, and slowing down clinical decisions.
Navigating Regulatory Complexity
Regulatory expectations are evolving in pace with emerging care technologies. With EU MDR recertification fees rising by 40% and review timelines extending to 1.5-2 years for high-risk devices, manufacturers cannot miss out on making regulatory readiness a strategic determinant of commercialization.
Demonstrating Clinical & Economic Value
Healthcare systems need stronger evidence to prove that innovation improves both affordability and outcomes. Though global healthcare spending crossed $9 trillion in 2025, only 23-25% of novel diagnostic technologies are generating the health-economic evidence needed to support broad reimbursement.
Balancing Clinical Accuracy with Operational Efficiency
Demand for faster diagnostic turnaround is rising at an unprecedented pace. However, pace should not come at the expense of clinical confidence. With the global point-of-care diagnostics market estimated to reach beyond $40 billion by 2030, companies need to improve their throughput while upholding operational reliability and diagnostic accuracy.
Accelerating Adoption Across Healthcare Ecosystems
Clinical validation alone is not enough to secure adoption. Most medical technologies typically need 12-18 months for significant market penetration because purchasing decisions rely on alignment across providers, payers, and administrators.
Scaling Interoperable and Connected Care
Integration of data across systems is a key barrier. Approx. 80% of health data from remote monitoring and wearable devices is still unused in clinical decision-making globally. With new regulatory reforms mandating interoperable data exchange and access to all acute-care equipment, the commercial viability of disconnected solutions becomes risky.
How We Drive Client Impact
See how we turn market signals into strategic clarity for the challenges that matter most.
Mounting uncertainty from emerging technologies, stringent clinical evidence requirements, and a fragmented startup ecosystem are redefining innovation in the MedTech industry.
By integrating innovation strategy, IP advisory, and technology intelligence, we are helping businesses drive business model innovation, evaluate clinical evidence, and optimize development roadmaps to de-risk investments and accelerate commercialization effectively.
We evaluate markets, customers, pricing, and partnerships to shape growth priorities and expansion pathways. Our capabilities encompass market assessment, market segmentation, growth opportunity analysis, and strategic alliances.
We develop decarbonization and circular economy strategies that connect resource efficiency and resilience with commercial objectives and long-term value creation.
Our work includes margin analysis, pricing and cost scenarios, portfolio exposure, supplier benchmarking, and alternative sourcing to support operational decisions.
Stellarix integrates early-warning monitoring, regulatory assessment, and future-state scenarios to inform mitigation, preparedness, and investment decisions.
Our expertise includes evaluating customer and stakeholder needs, reimbursement factors, value propositions, positioning, and commercialization strategies to identify effective market-entry approaches.
Stellarix unifies MedTech data, value chain reports, device registries, deal tracking, funding, and expert insights, enabling rapid and confident decisions.
Explore more in the MedTech Industry
Discover how precision diagnostics, connected care, and next-generation medical technologies are reshaping healthcare infrastructure, clinical adoption, and competitive positioning.
Outcomes That Speak for Themselves
A leading diagnostics company sought to expand into the at-home testing segment, targeting aging populations…
A market leader in surgical robots engaged Stellarix to enhance its orthopaedic portfolio and value…
The ophthalmic medical device industry is evolving rapidly, driven by digital transformation and sustainability goals.…